SYNGENE INTERNATIONAL LIMITED UNIT IX

Company Type: Factory/Manufacturing Facility and Research & Development Center.

Company Introduction:

SYNGENE INTERNATIONAL LIMITED UNIT IX is an operational unit of Syngene International Limited, a leading integrated research, development, and manufacturing organization (CRDMO) based in India. Syngene provides comprehensive scientific services spanning discovery research to commercial manufacturing for pharmaceutical, biotechnology, nutrition, animal health, and consumer goods companies globally. Unit IX functions as a key facility within Syngene's extensive network, contributing to its capabilities in areas such as drug substance manufacturing, process development, formulation development, or specialized research programs. It plays an integral role in Syngene's mission to accelerate the discovery and development of new molecules and products for its international clientele.

SYNGENE INTERNATIONAL LIMITED UNIT IX, like other units of Syngene International, primarily offers contract research, development, and manufacturing services to global pharmaceutical, biotechnology, nutrition, animal health, and specialty chemical companies. They do not typically produce or sell finished pharmaceutical products under their own brand directly to consumers or the market. Their offerings, which can be considered their "products" in a service-oriented business model, include:

Discovery Services:

Integrated Drug Discovery

Medicinal Chemistry

In Vitro Biology

In Vivo Pharmacology

Structural Biology

Antibody Discovery

Computational Chemistry

ADME DMPK (Absorption, Distribution, Metabolism, Excretion, Pharmacokinetics)

Development Services:

Process Chemistry and Scale-up

Analytical Development

Formulation Development

Preclinical Development (Toxicology, Pharmacokinetics, Pharmacodynamics studies)

Clinical Development (Bioanalytical services, Clinical operations)

Regulatory Affairs support

Manufacturing Services (Contract Development and Manufacturing Organization - CDMO):

Small Molecule Active Pharmaceutical Ingredient (API) Manufacturing (from clinical to commercial scale)

Biologics Drug Substance Manufacturing

Biologics Drug Product Manufacturing (including sterile fill and finish)

Oligonucleotide Manufacturing

Cell and Gene Therapy Manufacturing